Login
| TI Ref No : | 518201291 |
|---|---|
| Description : | Contract Awarded For Ex-ante Transparency Announcement § 130a Para. 8 Sgb V Lytenava (r) Active Ingredient: Bevacizumab Gamma Atc Code: S01la08 pharmaceutical Discount Contract § 130a Para. 8 Sgb V Medicine Name: Lytenava (r) Active Ingredient: Bevacizuma |
| Date : | 2025-05-21 |
| Deadline : | 2025-07-29 |
| Document Type : | Contracts |
